| Year |
Citation |
Score |
| 2024 |
Sauvé V, Stefan E, Croteau N, Goiran T, Fakih R, Bansal N, Hadzipasic A, Fang J, Murugan P, Chen S, Fon EA, Hirst WD, Silvian LF, Trempe JF, Gehring K. Activation of parkin by a molecular glue. Nature Communications. 15: 7707. PMID 39300082 DOI: 10.1038/s41467-024-51889-3 |
0.328 |
|
| 2015 |
Chang CF, Stefan E, Taylor RE. Total Synthesis and Structural Reassignment of Lyngbyaloside C Highlighted by Intermolecular Ketene Esterification. Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 10681-6. PMID 26101039 DOI: 10.1002/Chem.201502132 |
0.488 |
|
| 2015 |
Röck R, Bachmann V, Bhang HE, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E. In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs. Scientific Reports. 5: 11133. PMID 26099953 DOI: 10.1038/Srep11133 |
0.383 |
|
| 2015 |
Filteau M, Diss G, Torres-Quiroz F, Dubé AK, Schraffl A, Bachmann VA, Gagnon-Arsenault I, Chrétien AÈ, Steunou AL, Dionne U, Côté J, Bisson N, Stefan E, Landry CR. Systematic identification of signal integration by protein kinase A. Proceedings of the National Academy of Sciences of the United States of America. 112: 4501-6. PMID 25831502 DOI: 10.1073/Pnas.1409938112 |
0.373 |
|
| 2015 |
Stefan E, Taylor RE. 1,5-Hydride transfer protocol for the synthesis of β-branched polyketide structural units Tetrahedron Letters. 56: 3416-3419. DOI: 10.1016/J.Tetlet.2015.01.020 |
0.423 |
|
| 2014 |
Raffeiner P, Röck R, Schraffl A, Hartl M, Hart JR, Janda KD, Vogt PK, Stefan E, Bister K. In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential. Oncotarget. 5: 8869-78. PMID 25326649 DOI: 10.18632/Oncotarget.2588 |
0.538 |
|
| 2014 |
Hart JR, Garner AL, Yu J, Ito Y, Sun M, Ueno L, Rhee JK, Baksh MM, Stefan E, Hartl M, Bister K, Vogt PK, Janda KD. Inhibitor of MYC identified in a Kröhnke pyridine library. Proceedings of the National Academy of Sciences of the United States of America. 111: 12556-61. PMID 25114221 DOI: 10.1073/Pnas.1319488111 |
0.447 |
|
| 2013 |
Stefan E, Nalin AP, Taylor RE. Concise enantioselective synthesis of diospongins A and B. Tetrahedron. 69: 7706-7712. PMID 24058215 DOI: 10.1016/J.Tet.2013.05.081 |
0.411 |
|
| 2013 |
Lignitto L, Arcella A, Sepe M, Rinaldi L, Delle Donne R, Gallo A, Stefan E, Bachmann VA, Oliva MA, Tiziana Storlazzi C, L'Abbate A, Brunetti A, Gargiulo S, Gramanzini M, Insabato L, et al. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. Nature Communications. 4: 1822. PMID 23652010 DOI: 10.1038/Ncomms2791 |
0.314 |
|
| 2012 |
Stefan E, Taylor RE. Stereoselective synthesis of the C9-C19 fragment of lyngbyaloside B and C via ether transfer. Organic Letters. 14: 3490-3. PMID 22716968 DOI: 10.1021/Ol301455P |
0.434 |
|
| 2012 |
Haddach M, Pierre F, Regan CF, Borsan C, Michaux J, Stefan E, Kerdoncuff P, Schwaebe MK, Chua PC, Siddiqui-Jain A, Macalino D, Drygin D, O'Brien SE, Rice WG, Ryckman DM. Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs. Bioorganic & Medicinal Chemistry Letters. 22: 45-8. PMID 22169261 DOI: 10.1016/J.Bmcl.2011.11.087 |
0.409 |
|
| 2011 |
Pierre F, Stefan E, Nédellec AS, Chevrel MC, Regan CF, Siddiqui-Jain A, Macalino D, Streiner N, Drygin D, Haddach M, O'Brien SE, Anderes K, Ryckman DM. 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 21: 6687-92. PMID 21982499 DOI: 10.1016/J.Bmcl.2011.09.059 |
0.327 |
|
| 2011 |
Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, Michaux J, Nagasawa J, Schwaebe MK, Stefan E, Vialettes A, Whitten JP, Chen TK, Darjania L, Stansfield R, et al. Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer. Molecular and Cellular Biochemistry. 356: 37-43. PMID 21755459 DOI: 10.1007/S11010-011-0956-5 |
0.441 |
|
| 2011 |
Pierre F, O'Brien SE, Haddach M, Bourbon P, Schwaebe MK, Stefan E, Darjania L, Stansfield R, Ho C, Siddiqui-Jain A, Streiner N, Rice WG, Anderes K, Ryckman DM. Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties. Bioorganic & Medicinal Chemistry Letters. 21: 1687-91. PMID 21316963 DOI: 10.1016/J.Bmcl.2011.01.091 |
0.331 |
|
| 2011 |
Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, Michaux J, Nagasawa J, Schwaebe MK, Stefan E, Vialettes A, Whitten JP, Chen TK, Darjania L, Stansfield R, et al. Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. Journal of Medicinal Chemistry. 54: 635-54. PMID 21174434 DOI: 10.1021/Jm101251Q |
0.426 |
|
| 2009 |
O'Brien S, Haddach M, Borsan C, Michaux J, Kerdoncuff P, Schwaebe M, Pierre F, Stefan E, Nedellec AS, Siddiqui-Jain A, Streiner N, Macalino D, Drygin D, Ho C, Bliesath J, et al. Discovery of Selective Small Molecule Pan-Pim Kinase Inhibitors with Potent Oral Efficacy in Murine Xenograft Models. Blood. 114: 1726-1726. DOI: 10.1182/Blood.V114.22.1726.1726 |
0.429 |
|
| 2009 |
O'Brien S, Haddach M, Borsan C, Michaux J, Kerdoncuff P, Schwaebe M, Pierre F, Stefan E, Nedellec A, Siddiqui‐Jain A, Streiner N, Macalino D, Drygin D, Ho C, Bliesath J, et al. Abstract A246: Discovery of selective small molecule Pan‐Pim kinase inhibitors with potent oral efficacy in murine xenograft models Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A246 |
0.428 |
|
| 2007 |
Stefan E, Aquin S, Berger N, Landry CR, Nyfeler B, Bouvier M, Michnick SW. Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo. Proceedings of the National Academy of Sciences of the United States of America. 104: 16916-21. PMID 17942691 DOI: 10.1073/Pnas.0704257104 |
0.335 |
|
| 2007 |
Michnick SW, Ear PH, Manderson EN, Remy I, Stefan E. Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nature Reviews. Drug Discovery. 6: 569-82. PMID 17599086 DOI: 10.1038/Nrd2311 |
0.382 |
|
| Show low-probability matches. |